Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

AKRO Stock Annual Income Statement. Download in Excel

Akero Therapeutics Inc. logo

Akero Therapeutics Inc.

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

41.00
 
USD
  
0.01
  
(0.02%)
Previous close: 40.99  Open: 40.53  Bid: 40.71  Ask: 46.01
52 week range    
17.86   
   58.40
Mkt Cap: 3,065 M  Avg Vol (90 Days): 1,410,382
Last updated: Sunday 27th April 2025

Stock Rankings

64
MarketXLS Rank
60
Value
90
Technical
42
Quality
How are these ranks calculated?
Search for a stock

Financials

AKRO Income Statement

Annual
Invalid dateDec-19Dec-20Dec-21Dec-22Dec-23Dec-24
Basic EPS from continuing operations-2.9-2.52-2.89-2.87-2.89-3.75
Basic EPS total-2.9-2.52-2.89-2.87-2.89-3.75
Basic weighted shares outstanding15 M31 M35 M39 M53 M67 M
Diluted EPS total-2.9-2.52-2.89-2.87-2.89-3.75
Diluted normalized net income/share-2.89-2.87-2.89-3.75
Diluted weighted shares outstanding15 M31 M35 M39 M53 M67 M
GeneralAndAdministrativeExpense9 M15 M19 M30 M31 M38 M
Income before tax-44 M-79 M-101 M-112 M-152 M-252 M
Income taxes-9 M-21 M31 M42 M68 M65 M
Interest income4 M24 M38 M
InterestExpenseNonOperating739000.03 M5 M
MiscOtherSpecialCharges2 M947000.0109000.0-264000.0-79000.0-517000.0
Net income from total operations-44 M-79 M-101 M-112 M-152 M-252 M
NetIncomeCommonStockholders-44 M-79 M-101 M-112 M-152 M-252 M
NetIncomeContinuousOperations-44 M-79 M-101 M-112 M-152 M-252 M
NetNonOperatingInterestIncomeExpense-3 M21 M33 M
Normalized income-249 M
Operating income-46 M-80 M-101 M-115 M-173 M-285 M
Operating income before depreciation (EBITDA)-44 M-80 M-101 M-111 M-80 M-182 M
OperatingExpense46 M80 M101 M115 M173 M285 M
Other income net-2 M-950000.0-85000.04 M-233000.0-678000.0
OtherGandA9 M15 M19 M30 M31 M38 M
OtherOperatingExpenses-237000.0-407000.0-603000.0-746000.0-1 M-3 M
RentAndLandingFees305000.0
Research & development expense37 M65 M82 M85 M142 M247 M
ResearchExpense37 M65 M82 M85 M142 M247 M
Revenue per share204000.0448000.0607000.0
SalariesAndWages21 M30 M
Selling Gen & administrative expense9 M15 M19 M30 M31 M38 M
Total Income available for interest expense (EBIT)-44 M-80 M-101 M-111 M-80 M-183 M
Total common shares outstanding29 M35 M35 M47 M80 M
Total net income-44 M-79 M-101 M-112 M-152 M-252 M
Total ordinary shares80 M80 M80 M80 M80 M80 M
TotalExpenses46 M80 M101 M115 M173 M285 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader